Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the treatment profile of approximately 1,000 adult
patients with gastroesophageal reflux who begin raberpazole sodium treatment for 4 months,
and assess patients' adherence to the study drug.